
Lyxumia Insulin Pen
Price Trend: 1.20 - 1.50 USD / Box
Get Latest Price
Minimum Order Quantity :
1 Box
In Stock
Product Specifications
| Material | Plastic |
| Dimensions | 10cm x 2cm |
| Dose | 10/20 mcg |
| Capacity | 14 doses |
| Needle | Disposable |
| Packaging | Carton box |
| Color | Purple |
| Features | Precise dosing, Easy to use, Effective treatment, Reduced HbA1c, Weight loss, Once daily dose, Low hypoglycemia risk |
| FOB Port | USA |
| Payment Terms | Cash on Delivery (COD), Days after Acceptance (DA), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Western Union, Paypal, Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque, Cash Advance (CA) |
| Supply Ability | 100000 Per Day |
| Delivery Time | 5 Days |
| Sample Available | Yes |
| Sample Policy | Free samples are available |
| Packaging Details | lyxumia |
| Main Export Market(s) | Asia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa |
| Certifications | lyxumia |
Product Overview
Key Features
Properties of Lyxumia:
Significant reduction in HbA1c with pronounced effect on postprandial blood sugar.
Weight reduction, even in combination with basal insulin.
Lixisenatide is a selective GLP-1 receptor agonist. The GLP-1 receptor is the target for natural GLP-1, an endogenous incretin hormone that enhances glucose-dependent insulin secretion from pancreatic beta cells. The effect is mediated through a specific interaction with GLP-1 receptors, leading to an increase in intracellular cyclic adenosine monophosphate (cAMP). Lixisenatide stimulates insulin secretion in response to elevated blood glucose levels, but not at normal blood glucose levels. This reduces the risk of hypoglycemia. At the same time, the secretion of glucagon is reduced, but the normal mechanism of glucagon secretion is preserved during hypoglycemia. Lixisenatide delays gastric emptying, thereby reducing the rate of glucose increase in the blood after a meal.
Practical information:
Dosage and administration of Lyxumia:
- The starting dose is 10 micrograms once daily.
- The maintenance dose is 20 micrograms daily, starting from day 15.
- Specific blood sugar monitoring is not required when using Lyxumia.
- It is administered subcutaneously in the thigh, abdomen, or upper arm.
- Inject within 0-60 minutes before a meal (at the same mealtime each day).
- The patient takes 10 micrograms of Lyxumia for 14 days. After this, the patient continues treatment with 20 micrograms per day. Each pen contains 14 doses, and one pen lasts for two weeks. Each pack is sufficient for four weeks.
For the first three months, the patient will need: one starter pack and two maintenance packs.
Company Details
Business Type
Exporter, Importer, Manufacturer, Service Provider, Distributor, Supplier, Trading Company, Wholesaler, Retailer, Dealer, Fabricator, Producer
Employee Count
50
Establishment
2017
Working Days
Monday To Sunday
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
California, Missouri
Export Manager
Mr Timothy Florian
Address
28955, Avenue Sherman Valencia, California, Missouri, 91355, United States
insulin pen in California
Report incorrect details
























